Stocktwits on MSN8h
Tonix Pharma Stock’s Retail Chatter Explodes After FDA Nod For New Drug Application
Tonix Pharmaceuticals was the most active symbol on Stocktwits before the bell on Wednesday as shares of the clinical-stage ...
Morningstar9h
The Fed was more lucky than right in the fight against inflation - and still getting it wrong, these researchers say.
Happy Fed day to all who observe. Not everyone celebrates. There is of course the debate for this decision, whether the data really supports the interest rate cut that basically everybody seems to ...
Morningstar10h
The Fed was more lucky than right in the fight against inflation, these researchers say.
Happy Fed day to all who observe. Not everyone celebrates. There is of course the debate for this decision, whether the data really supports the interest rate cut that basically everybody seems to ...
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Shares of Corvus Pharmaceuticals, Inc. CRVS +18.3% + Free Alerts rose sharply in today's pre-market trading after the company ...
The Globe and Mail1d
This Micro Cap Is Getting Bid Up Prior To Opening Bell
Traders were quick to snatch up shares of Tonix Pharmaceuticals Holding Corp. (Nassdaq:TNXP) following the announcement, with ...
What's Going On With Tonix Pharmaceuticals Stock Today?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...
kalkinemedia1d
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL
(Nasdaq: TNXP) announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ...
Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug
Tonix Pharmaceuticals Holding said the Food and Drug Administration has accepted its application seeking approval of its TNX-102 SL product candidate for the chronic pain condition fibromyalgia.
Tonix Pharma’s TNX-102 SL Nears FDA Approval Milestone
Tonix Pharma ( (TNXP) ) has provided an announcement.
Tonix Pharmaceuticals announces FDA acceptance of NDA for TNX-102 SL
Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration, FDA, has accepted the filing of its New Drug Application, ...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review ...
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 ...